$USPH
U S PHYSICAL THERAPY INC /NV Stock $usph

$usph Overview Financials Valuation SEC Filings Company Website

2013 Q4 Form 10-K Financial Statement

#000119312514093159 Filed on March 11, 2014

Income Statement

Concept	2013 Q4	2013 Q3	2013 Q2
Revenue	$68.61M	$65.83M	$66.87M
YoY Change	9.98%	6.0%	5.48%
Cost Of Revenue	$52.20M	$49.70M	$49.30M
YoY Change	8.98%	6.42%	8.11%
Gross Profit	$16.40M	$16.13M	$17.31M
YoY Change	13.1%	4.44%	1.84%
Gross Profit Margin	23.9%	24.5%	25.88%
Selling, General & Admin	$6.800M	$6.200M	$6.500M
YoY Change	11.48%	5.08%	3.17%
% of Gross Profit	41.46%	38.44%	37.56%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.380M	$1.450M	$1.380M
YoY Change	8.66%	5.84%	4.55%
% of Gross Profit	8.41%	8.99%	7.97%
Operating Expenses	$6.800M	$6.200M	$6.500M
YoY Change	11.48%	5.08%	3.17%
Operating Profit	$9.372M	$9.904M	$11.06M
YoY Change	12.9%	3.88%	2.34%
Interest Expense	-$100.0K	$133.0K	$130.0K
YoY Change	0.0%	-6.34%	-10.34%
% of Operating Profit	-1.07%	1.34%	1.18%
Other Income/Expense, Net
YoY Change
Pretax Income	$9.200M	$9.773M	$10.56M
YoY Change	12.2%	4.03%	0.97%
Income Tax	$3.400M	$3.017M	$3.181M
% Of Pretax Income	36.96%	30.87%	30.14%
Net Earnings	$3.861M	$227.0K	$4.914M
YoY Change	-4.5%	-95.03%	1.34%
Net Earnings / Revenue	5.63%	0.34%	7.35%
Basic Earnings Per Share	$0.32	$0.02	$0.41
Diluted Earnings Per Share	$0.32	$0.02	$0.41
COMMON SHARES
Basic Shares Outstanding	12.10M shares	12.11M shares	12.09M shares
Diluted Shares Outstanding	12.12M shares	12.12M shares	12.11M shares

Balance Sheet

Concept	2013 Q4	2013 Q3	2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.90M	$12.10M	$10.30M
YoY Change	10.26%	13.08%	17.05%
Cash & Equivalents	$12.90M	$12.12M	$10.29M
Short-Term Investments
Other Short-Term Assets	$4.098M	$4.482M	$1.878M
YoY Change	-31.41%	-10.36%	-64.57%
Inventory
Prepaid Expenses
Receivables	$32.70M	$28.60M	$29.30M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$49.66M	$45.16M	$41.43M
YoY Change	9.57%	2.4%	-7.11%
LONG-TERM ASSETS
Property, Plant & Equipment	$14.96M	$13.52M	$13.76M
YoY Change	14.94%	5.59%	6.64%
Goodwill	$144.0M	$105.2M	$112.2M
YoY Change	43.68%
Intangibles	$14.48M	$14.67M	$14.03M
YoY Change	19.21%
Long-Term Investments
YoY Change
Other Assets	$1.081M	$1.078M	$967.0K
YoY Change	3.74%	7.8%	-30.93%
Total Long-Term Assets	$174.5M	$134.5M	$141.0M
YoY Change	38.04%	6.92%	11.91%
TOTAL ASSETS
Total Short-Term Assets	$49.66M	$45.16M	$41.43M
Total Long-Term Assets	$174.5M	$134.5M	$141.0M
Total Assets	$224.1M	$179.7M	$182.4M
YoY Change	30.53%	5.74%	6.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.700M	$1.300M	$1.300M
YoY Change	0.0%	-23.53%	-7.14%
Accrued Expenses	$20.63M	$14.78M	$15.30M
YoY Change	46.11%	16.37%	7.73%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$825.0K	$575.0K	$800.0K
YoY Change	79.74%	-4.17%	33.33%
Total Short-Term Liabilities	$23.17M	$16.66M	$17.37M
YoY Change	42.1%	11.78%	7.24%
LONG-TERM LIABILITIES
Long-Term Debt	$40.65M	$14.55M	$16.15M
YoY Change	131.29%	-10.74%	-20.44%
Other Long-Term Liabilities	$4.196M	$728.0K	$706.0K
YoY Change	84.12%	-68.35%	-55.88%
Total Long-Term Liabilities	$44.85M	$15.28M	$16.86M
YoY Change	125.88%	-17.86%	-23.03%
TOTAL LIABILITIES
Total Short-Term Liabilities	$23.17M	$16.66M	$17.37M
Total Long-Term Liabilities	$44.85M	$15.28M	$16.86M
Total Liabilities	$69.01M	$32.95M	$35.20M
YoY Change	86.25%	-34.76%	-36.35%
SHAREHOLDERS EQUITY
Retained Earnings	$119.2M	$116.6M	$117.5M
YoY Change	7.08%
Common Stock	$40.71M	$39.37M	$38.71M
YoY Change	8.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$31.63M	$31.63M	$31.63M
YoY Change	0.0%
Treasury Stock Shares	$2.215M	2.215M shares	2.215M shares
Shareholders Equity	$128.3M	$124.3M	$124.6M
YoY Change
Total Liabilities & Shareholders Equity	$224.1M	$179.7M	$182.4M
YoY Change	30.53%	5.74%	6.93%

Cashflow Statement

Concept	2013 Q4	2013 Q3	2013 Q2
OPERATING ACTIVITIES
Net Income	$3.861M	$227.0K	$4.914M
YoY Change	-4.5%	-95.03%	1.34%
Depreciation, Depletion And Amortization	$1.380M	$1.450M	$1.380M
YoY Change	8.66%	5.84%	4.55%
Cash From Operating Activities	$15.94M	$8.140M	$15.87M
YoY Change	61.01%	-21.58%	15.0%
INVESTING ACTIVITIES
Capital Expenditures	-$1.180M	-$1.070M	-$1.120M
YoY Change	-7.81%	5.94%	7.69%
Acquisitions
YoY Change
Other Investing Activities	-$36.46M	-$300.0K	-$5.890M
YoY Change	2414.48%	-44.44%	-5.46%
Cash From Investing Activities	-$37.64M	-$1.370M	-$7.010M
YoY Change	1278.75%	-11.61%	-3.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	22.48M	-4.940M	-8.850M
YoY Change	-463.75%	-29.02%	8.59%
NET CHANGE
Cash From Operating Activities	15.94M	8.140M	15.87M
Cash From Investing Activities	-37.64M	-1.370M	-7.010M
Cash From Financing Activities	22.48M	-4.940M	-8.850M
Net Change In Cash	780.0K	1.830M	10.00K
YoY Change	-21.21%	-2.14%	-100.62%
FREE CASH FLOW
Cash From Operating Activities	$15.94M	$8.140M	$15.87M
Capital Expenditures	-$1.180M	-$1.070M	-$1.120M
Free Cash Flow	$17.12M	$9.210M	$16.99M
YoY Change	53.13%	-19.14%	14.49%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2011	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2011Q3	us-gaap	Business Acquisition Percentage Of Voting Interests Acquired BusinessAcquisitionPercentageOfVotingInterestsAcquired	0.51	pure
CY2011Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0325	pure
CY2011Q3	us-gaap	Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue	8095000
CY2011Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets	902000
CY2011Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables	1341000
CY2011Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	-581000
CY2011Q3	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	11263000
CY2011Q3	usph	Payments To Acquire Businesses Consideration PaymentsToAcquireBusinessesConsideration	8130000
CY2011Q3	usph	Business Acquisition Purchase Price Allocation Notes Payable Number Of Installment BusinessAcquisitionPurchasePriceAllocationNotesPayableNumberOfInstallment	2	Installment
CY2011Q3	usph	Business Acquisition Purchase Price Allocation Intangible Assets Other Than Goodwill Net BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsOtherThanGoodwillNet	300000
CY2011Q3	usph	Percentage Of Tax Deductible Goodwill PercentageOfTaxDeductibleGoodwill	0.51	pure
CY2011Q3	usph	Business Acquisition Cost Of Acquired Entity Purchase Price Net BusinessAcquisitionCostOfAcquiredEntityPurchasePriceNet	8226000
CY2011Q3	usph	Business Acquisition Purchase Price Allocation Referral Relationships BusinessAcquisitionPurchasePriceAllocationReferralRelationships	1100000
CY2011Q3	usph	Business Acquisition Purchase Price Allocation Trade Name BusinessAcquisitionPurchasePriceAllocationTradeName	1900000
CY2011Q3	usph	Business Acquisition Cost Of Acquired Entity Debt Issued BusinessAcquisitionCostOfAcquiredEntityDebtIssued	200000
CY2011Q3	usph	Business Acquisition Purchase Price Allocation Net Tangible Asset BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset	1662000
CY2011Q4	usph	Business Acquisition Purchase Price Allocation Note Payable BusinessAcquisitionPurchasePriceAllocationNotePayable	3800000
CY2011Q4	usph	Business Acquisition Cost Of Acquired Entity Loan Forgiveness BusinessAcquisitionCostOfAcquiredEntityLoanForgiveness	100000
CY2012Q2	us-gaap	Business Acquisition Percentage Of Voting Interests Acquired BusinessAcquisitionPercentageOfVotingInterestsAcquired	0.70	pure
CY2012Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0325	pure
CY2012Q2	usph	Percentage Of Tax Deductible Goodwill PercentageOfTaxDeductibleGoodwill	0.70	pure
CY2012Q2	usph	Business Acquisition Cost Of Acquired Entity Debt Issued BusinessAcquisitionCostOfAcquiredEntityDebtIssued	250000
CY2013Q4	us-gaap	Business Acquisition Percentage Of Voting Interests Acquired BusinessAcquisitionPercentageOfVotingInterestsAcquired	0.60	pure
CY2013Q4	us-gaap	Business Acquisition Percentage Of Voting Interests Acquired BusinessAcquisitionPercentageOfVotingInterestsAcquired	0.90	pure
CY2013Q4	usph	Business Acquisition Cost Of Acquired Entity Debt Issued BusinessAcquisitionCostOfAcquiredEntityDebtIssued	500000
CY2009Q1	usph	Maximum Percentage Of Repurchase Of Common Stock MaximumPercentageOfRepurchaseOfCommonStock	0.10	pure
CY2009Q1	usph	Repurchases Of Common Stock RepurchasesOfCommonStock	1200000	shares
CY2009Q1	usph	Bank Credit Agreement To Permit Share Repurchases Of Common Stock BankCreditAgreementToPermitShareRepurchasesOfCommonStock	15000000
CY2012Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	17400000
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12198365	shares
CY2011Q2	us-gaap	Business Acquisition Percentage Of Voting Interests Acquired BusinessAcquisitionPercentageOfVotingInterestsAcquired	1.00	pure
CY2011Q2	usph	Business Acquisition Purchase Price Allocation Notes Payable Number Of Installment BusinessAcquisitionPurchasePriceAllocationNotesPayableNumberOfInstallment	2	Installment
CY2012Q2	usph	Percentage Of Tax Deductible Goodwill PercentageOfTaxDeductibleGoodwill	0.67	pure
CY2012Q2	usph	Business Acquisition Cost Of Acquired Entity Purchase Price Net BusinessAcquisitionCostOfAcquiredEntityPurchasePriceNet	1938000
CY2012Q2	usph	Business Acquisition Cost Of Acquired Entity Debt Issued BusinessAcquisitionCostOfAcquiredEntityDebtIssued	100000
CY2013Q2	dei	Entity Public Float EntityPublicFloat	250528000
CY2008Q4	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	2250000	shares
CY2010Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.30
CY2010Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	723890	shares
CY2010Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	116383000
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9179000
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	348810	shares
CY2011Q4	us-gaap	Minority Interest Ownership Percentage By Parent MinorityInterestOwnershipPercentageByParent	0.078	pure
CY2011Q4	us-gaap	Minority Interest Ownership Percentage By Noncontrolling Owners MinorityInterestOwnershipPercentageByNoncontrollingOwners	0.922	pure
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.30
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	348810	shares
CY2011Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	121580000
CY2011Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2011Q4	us-gaap	Goodwill Goodwill	92750000
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9983000
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	75840	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14129651	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.71
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	75840	shares
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2012Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2214737	shares
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	14116000
CY2012Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	17575000
CY2012Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	575000
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	44158000
CY2012Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2671000
CY2012Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2741000
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16307000
CY2012Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	800000
CY2012Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	134659000
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2279000
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	117323000
CY2012Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2012Q4	us-gaap	Minority Interest MinorityInterest	17336000
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	37489000
CY2012Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	514000
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	111321000
CY2012Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1014000
CY2012Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1732000
CY2012Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	894000
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	141000
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	171714000
CY2012Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	1604000
CY2012Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	175000
CY2012Q4	us-gaap	Long Term Debt LongTermDebt	18034000
CY2012Q4	us-gaap	Liabilities Liabilities	37055000
CY2012Q4	us-gaap	Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue	2892000
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2012Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	459000
CY2012Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets	525000
CY2012Q4	us-gaap	Assets Current AssetsCurrent	45322000
CY2012Q4	us-gaap	Goodwill Goodwill	100188000
CY2012Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	1703000
CY2012Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	20858000
CY2012Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12146000
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1042000
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	1059000
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1727000
CY2012Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	590000
CY2012Q4	us-gaap	Assets Assets	171714000
CY2012Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables	410000
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11671000
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	57174000
CY2012Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	-333000
CY2012Q4	us-gaap	Deferred Income Taxes And Other Tax Receivable Current DeferredIncomeTaxesAndOtherTaxReceivableCurrent	4200000
CY2012Q4	us-gaap	Other Assets Current OtherAssetsCurrent	5975000
CY2012Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	22000
CY2012Q4	us-gaap	Treasury Stock Value TreasuryStockValue	31628000
CY2012Q4	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	8147000
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	607000
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13016000
CY2012Q4	usph	Payments To Acquire Businesses Consideration PaymentsToAcquireBusinessesConsideration	8279000
CY2012Q4	usph	Deferred Tax Liabilities Depreciation And Amortization DeferredTaxLiabilitiesDepreciationAndAmortization	2166000
CY2012Q4	usph	Business Acquisition Purchase Price Allocation Notes Payable Number Of Installment BusinessAcquisitionPurchasePriceAllocationNotesPayableNumberOfInstallment	2	Installment
CY2012Q4	usph	Business Acquisition Purchase Price Allocation Intangible Assets Other Than Goodwill Net BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsOtherThanGoodwillNet	265000
CY2012Q4	usph	Furniture And Equipment Gross FurnitureAndEquipmentGross	36316000
CY2012Q4	usph	Business Acquisition Purchase Price Allocation Referral Relationships BusinessAcquisitionPurchasePriceAllocationReferralRelationships	857000
CY2012Q4	usph	Patient Accounts Receivable PatientAccountsReceivable	25973000
CY2012Q4	usph	Business Acquisition Purchase Price Allocation Trade Name BusinessAcquisitionPurchasePriceAllocationTradeName	1300000
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	20625000
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	18263000
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0
CY2012Q4	usph	Allowance For Doubtful Accounts Patient Accounts Receivable AllowanceForDoubtfulAccountsPatientAccountsReceivable	1595000
CY2012Q4	usph	Business Acquisition Cost Of Acquired Entity Debt Issued BusinessAcquisitionCostOfAcquiredEntityDebtIssued	350000
CY2012Q4	usph	Deferred Tax Assets Lease Obligations DeferredTaxAssetsLeaseObligations	39000
CY2012Q4	usph	Business Acquisition Purchase Price Allocation Net Tangible Asset BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset	602000
CY2012Q4	usph	Salaries And Related Costs Current SalariesAndRelatedCostsCurrent	8941000
CY2012Q4	usph	Group Health Insurance Claims Current GroupHealthInsuranceClaimsCurrent	991000
CY2012Q4	usph	Patients And Payors Related Liability PatientsAndPayorsRelatedLiability	1513000
CY2012Q4	usph	Deferred Tax Assets Acquisition Of Noncontrolling Interest DeferredTaxAssetsAcquisitionOfNoncontrollingInterest	800000
CY2013Q4	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	43	State
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	38700	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14315882	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	18.36
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	38700	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	2350000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2214737	shares
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2013Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	40650000
CY2013Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	546000
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	45896000
CY2013Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4545000
CY2013Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4783000
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	67622000
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	7859000
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	23172000
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	1902000
CY2013Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	4104000
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	400000
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	151017000
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4196000
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	128290000
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	40569000
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	825000
CY2013Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2013Q4	us-gaap	Minority Interest MinorityInterest	22727000
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	4274000
CY2013Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	40000000
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	198000
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	119206000
CY2013Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2977000
CY2013Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1722000
CY2013Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	996000
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	143000
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	224135000
CY2013Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	3459000
CY2013Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	650000
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	650000
CY2013Q4	us-gaap	Long Term Debt LongTermDebt	41475000
CY2013Q4	us-gaap	Liabilities Liabilities	69014000
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	12761000
CY2013Q4	us-gaap	Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue	10541000
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	22563000
CY2013Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	825000
CY2013Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets	2283000
CY2013Q4	us-gaap	Assets Current AssetsCurrent	49660000
CY2013Q4	us-gaap	Goodwill Goodwill	143955000
CY2013Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	1844000
CY2013Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	21891000
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	14479000
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1081000
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	1280000
CY2013Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1806000
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	482000
CY2013Q4	us-gaap	Assets Assets	224135000
CY2013Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables	3895000
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12898000
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	60856000
CY2013Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	654000
CY2013Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	-1082000
CY2013Q4	us-gaap	Deferred Income Taxes And Other Tax Receivable Current DeferredIncomeTaxesAndOtherTaxReceivableCurrent	2200000
CY2013Q4	us-gaap	Other Assets Current OtherAssetsCurrent	4098000
CY2013Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	31628000
CY2013Q4	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	52213000
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	449000
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14960000
CY2013Q4	usph	Payments To Acquire Businesses Consideration PaymentsToAcquireBusinessesConsideration	47928000
CY2013Q4	usph	Number Of Clinics Operated NumberOfClinicsOperated	472	Clinic
CY2013Q4	usph	Deferred Tax Liabilities Depreciation And Amortization DeferredTaxLiabilitiesDepreciationAndAmortization	4237000
CY2013Q4	usph	Business Acquisition Purchase Price Allocation Notes Payable Number Of Installment BusinessAcquisitionPurchasePriceAllocationNotesPayableNumberOfInstallment	2	Installment
CY2013Q4	usph	Business Acquisition Purchase Price Allocation Intangible Assets Other Than Goodwill Net BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsOtherThanGoodwillNet	160000
CY2013Q4	usph	Expected Reduction In Medicare Spending Percentage ExpectedReductionInMedicareSpendingPercentage	0.02	pure
CY2013Q4	usph	Furniture And Equipment Gross FurnitureAndEquipmentGross	38965000
CY2013Q4	usph	Business Acquisition Purchase Price Allocation Referral Relationships BusinessAcquisitionPurchasePriceAllocationReferralRelationships	400000
CY2013Q4	usph	Patient Accounts Receivable PatientAccountsReceivable	30820000
CY2013Q4	usph	Business Acquisition Purchase Price Allocation Trade Name BusinessAcquisitionPurchasePriceAllocationTradeName	600000
CY2013Q4	usph	Allowance For Doubtful Accounts Patient Accounts Receivable AllowanceForDoubtfulAccountsPatientAccountsReceivable	1430000
CY2013Q4	usph	Business Acquisition Cost Of Acquired Entity Debt Issued BusinessAcquisitionCostOfAcquiredEntityDebtIssued	1300000
CY2013Q4	usph	Deferred Tax Assets Lease Obligations DeferredTaxAssetsLeaseObligations	77000
CY2013Q4	usph	Business Acquisition Purchase Price Allocation Net Tangible Asset BusinessAcquisitionPurchasePriceAllocationNetTangibleAsset	5096000
CY2013Q4	usph	Salaries And Related Costs Current SalariesAndRelatedCostsCurrent	11686000
CY2013Q4	usph	Group Health Insurance Claims Current GroupHealthInsuranceClaimsCurrent	2023000
CY2013Q4	usph	Patients And Payors Related Liability PatientsAndPayorsRelatedLiability	2371000
CY2013Q4	usph	Deferred Tax Assets Acquisition Of Noncontrolling Interest DeferredTaxAssetsAcquisitionOfNoncontrollingInterest	400000
CY2013Q4	usph	Employee Compensation Future Payment Due Next Fiscal Year EmployeeCompensationFuturePaymentDueNextFiscalYear	18100000
CY2013Q4	usph	Employee Compensation Future Payment Due Next Fiscal Year Thereafter EmployeeCompensationFuturePaymentDueNextFiscalYearThereafter	4500000
CY2013Q4	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	1700000
CY2013Q4	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	35500000
CY2013Q4	usph	Business Acquisition Number Of Installments To Payment Of Purchase Consideration BusinessAcquisitionNumberOfInstallmentsToPaymentOfPurchaseConsideration	2	Installment
CY2013Q3	usph	Facilities Previously Closed FacilitiesPreviouslyClosed	1	Facility
CY2011Q4	usph	Business Acquisition Purchase Price Adjustment Received BusinessAcquisitionPurchasePriceAdjustmentReceived	1500000
CY2011Q4	usph	Business Acquisition Cost Of Acquired Entity Loan Forgiveness Percentage BusinessAcquisitionCostOfAcquiredEntityLoanForgivenessPercentage	0.30	pure
CY2012Q2	usph	Sale Of Proportion Of Interest In Acquisition To Limited Partner SaleOfProportionOfInterestInAcquisitionToLimitedPartner	0.50	pure
CY2012Q2	usph	Remaining Proportion Of Acquisition Owned RemainingProportionOfAcquisitionOwned	0.01	pure
CY2011Q3	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	7930000
CY2012Q3	usph	Business Acquisition Principal Installments Payable At Cost Of Acquired By Entity At Accrued Interest BusinessAcquisitionPrincipalInstallmentsPayableAtCostOfAcquiredByEntityAtAccruedInterest	100000
CY2009Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	859499	shares
CY2009Q1	usph	Additional Estimated Repurchase Of Common Stock AdditionalEstimatedRepurchaseOfCommonStock	340501	shares
CY2012Q2	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	6090000
CY2012Q4	usph	Facilities Previously Closed FacilitiesPreviouslyClosed	1	Facility
CY2010	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y7M6D
CY2011	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.18
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	156750	shares
CY2011	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2011	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.75
CY2011	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.32
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2011	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11977000	shares
CY2011	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.340	pure
CY2011	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.78
CY2011	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y7M6D
CY2011	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.003	pure
CY2011	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2011	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	163000	shares
CY2011	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	0.18
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	32655000
CY2011	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.60
CY2011	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	13.92
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	19.94
CY2011	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11814000	shares
CY2011	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	12.51
CY2011	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	375080	shares
CY2011	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.034	pure
CY2011	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.57
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2011	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	18.80
CY2011	us-gaap	Interest Paid Net InterestPaidNet	325000
CY2011	us-gaap	Increase Decrease In Accounts Receivable And Other Operating Assets IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets	990000
CY2011	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	8096000
CY2011	us-gaap	Gross Profit GrossProfit	55868000
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	36377000
CY2011	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	9037000
CY2011	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	3789000
CY2011	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	250000
CY2011	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	3104000
CY2011	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	9451000
CY2011	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	100900000
CY2011	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	2162000
CY2011	us-gaap	Profit Loss ProfitLoss	29783000
CY2011	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1972000
CY2011	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	217000
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	31428000
CY2011	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	5719000
CY2011	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	18812000
CY2011	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	9767000
CY2011	us-gaap	Net Income Loss NetIncomeLoss	20974000
CY2011	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	225804000
CY2011	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4656000
CY2011	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	26679000
CY2011	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	217000
CY2011	us-gaap	Sales Revenue Net SalesRevenueNet	231523000
CY2011	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	3222000
CY2011	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	8809000
CY2011	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1190000
CY2011	us-gaap	Costs And Expenses CostsAndExpenses	175655000
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-245000
CY2011	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	217000
CY2011	us-gaap	Dividends Common Stock DividendsCommonStock	3789000
CY2011	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	437000
CY2011	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3833000
CY2011	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	6000
CY2011	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	4656000
CY2011	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	9767000
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3160000
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	2032000
CY2011	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3778000
CY2011	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	804000
CY2011	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-511000
CY2011	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	19400000
CY2011	us-gaap	Interest Expense InterestExpense	496000
CY2011	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	963000
CY2011	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	9979000
CY2011	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	13083000
CY2011	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	3603000
CY2011	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	-1399000
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-31606000
CY2011	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	98000
CY2011	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-275000
CY2011	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	118900000
CY2011	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	230000
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5449000
CY2011	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	58000
CY2011	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	695000
CY2011	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	5865000
CY2011	us-gaap	Restructuring Charges RestructuringCharges	59000
CY2011	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0
CY2011	us-gaap	Labor And Related Expense LaborAndRelatedExpense	124820000
CY2011	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0
CY2011	us-gaap	Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent	142000
CY2011	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	6376000
CY2011	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9698000
CY2011	usph	Compensation Expense Restricted Stock CompensationExpenseRestrictedStock	2032000
CY2011	usph	Acquisitions Of Noncontrolling Interests AcquisitionsOfNoncontrollingInterests	20439000
CY2011	usph	Proceeds From Settlement Of Purchase Price ProceedsFromSettlementOfPurchasePrice	-3835000
CY2011	usph	Effective Income Tax Rate Reconciliation Nontaxable Gain EffectiveIncomeTaxRateReconciliationNontaxableGain	0.047	pure
CY2011	usph	Income Tax Reconciliation Deductible Losses IncomeTaxReconciliationDeductibleLosses
CY2011	usph	Acquisition Of Noncontrolling Interest AcquisitionOfNoncontrollingInterest	367000
CY2011	usph	Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans	199000
CY2011	usph	Purchase Of Business Seller Financing Portion PurchaseOfBusinessSellerFinancingPortion	200000
CY2011	usph	Interest And Other Income Net InterestAndOtherIncomeNet	5445000
CY2011	usph	Increase Decrease In Patient Accounts Receivable IncreaseDecreaseInPatientAccountsReceivable	5147000
CY2011	usph	Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Amount Changes Purchase Consideration Charge From Undistributed Earning ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestAmountChangesPurchaseConsiderationChargeFromUndistributedEarning	48000
CY2011	usph	Rent Clinic Supplies Contract Labor And Other RentClinicSuppliesContractLaborAndOther	46998000
CY2011	usph	Gain On Purchase Price Settlement GainOnPurchasePriceSettlement	5435000
CY2011	usph	Corporate Office Costs CorporateOfficeCosts	24440000
CY2011	usph	Voting Interest Held By Director And Founder VotingInterestHeldByDirectorAndFounder	0.17	pure
CY2011	usph	Sale Of Voting Interest By Director And Founder SaleOfVotingInterestByDirectorAndFounder	0.170	pure
CY2011	usph	Remaining Voting Interest Held By Director And Founder RemainingVotingInterestHeldByDirectorAndFounder	0.020	pure
CY2011	usph	Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Future Tax Benefit ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesFutureTaxBenefit	23000
CY2011	usph	Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Consideration Amount Charge From Additional Paid Up Capital ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseConsiderationAmountChargeFromAdditionalPaidUpCapital	36000
CY2011	usph	Effective Income Tax Rate Reconciliation Deductible Losses EffectiveIncomeTaxRateReconciliationDeductibleLosses	0.000	pure
CY2011	usph	Income Tax Reconciliation Income Tax Expense Benefit Non Taxable Gain IncomeTaxReconciliationIncomeTaxExpenseBenefitNonTaxableGain	-1342000
CY2011	usph	Gain Loss On Sale Or Abandonment Of Assets Net GainLossOnSaleOrAbandonmentOfAssetsNet	-182000
CY2013	dei	Trading Symbol TradingSymbol	USPH
CY2013	dei	Entity Registrant Name EntityRegistrantName	U S PHYSICAL THERAPY INC /NV
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013	dei	Amendment Flag AmendmentFlag	false
CY2013	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2013	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013	dei	Document Type DocumentType	10-K
CY2013	dei	Document Period End Date DocumentPeriodEndDate	2013-12-31
CY2013	dei	Entity Central Index Key EntityCentralIndexKey	0000885978
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2013	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2013	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.40
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	783563	shares
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.05
CY2013	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.40
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2013	us-gaap	Weighted Average Basic Shares Outstanding Pro Forma WeightedAverageBasicSharesOutstandingProForma	12050	shares
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12082000	shares
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350	pure
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2013	us-gaap	Pro Forma Weighted Average Shares Outstanding Diluted ProFormaWeightedAverageSharesOutstandingDiluted	12069	shares
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.05
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y7M6D
CY2013	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.50	pure
CY2013	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	1.60
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.411	pure
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.003	pure
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2013	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	19000	shares
CY2013	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	1.59
CY2013	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.40
CY2013	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	5	Clinic
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	44795000
CY2013	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.45
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	15.25
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	648346	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	23.52
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12063000	shares
CY2013	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	258283000
CY2013	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	12.60
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y7M6D
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	879391	shares
CY2013	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.061	pure
CY2013	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.45
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2013	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<div> <p style="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"> <b><i>Use of Estimates</i></b></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> In preparing the Company’s consolidated financial statements, management makes certain estimates and assumptions, especially in relation to, but not limited to, goodwill impairment, allowance for receivables, tax provision and contractual allowances, that affect the amounts reported in the consolidated financial statements and related disclosures. Actual results may differ from these estimates.</p> </div>
CY2013	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	18.42
CY2013	us-gaap	Net Income Loss NetIncomeLoss	12723000
CY2013	us-gaap	Interest Paid Net InterestPaidNet	352000
CY2013	us-gaap	Increase Decrease In Accounts Receivable And Other Operating Assets IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets	5000
CY2013	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	10541000
CY2013	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	238000
CY2013	us-gaap	Gross Profit GrossProfit	64701000
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	38239000
CY2013	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4111000
CY2013	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	4838000
CY2013	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	459000
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-5007000
CY2013	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	46628000
CY2013	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	6058000
CY2013	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	128200000
CY2013	us-gaap	Business Combination Separately Recognized Transactions Revenues And Gains Recognized BusinessCombinationSeparatelyRecognizedTransactionsRevenuesAndGainsRecognized	505000
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-4769000
CY2013	us-gaap	Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax	19231000
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	47000
CY2013	us-gaap	Profit Loss ProfitLoss	20996000
CY2013	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1803000
CY2013	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	695000
CY2013	us-gaap	Business Combination Separately Recognized Transactions Net Gains And Losses BusinessCombinationSeparatelyRecognizedTransactionsNetGainsAndLosses	119000
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	38770000
CY2013	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	5775000
CY2013	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	275511000
CY2013	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	17492000
CY2013	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	9164000
CY2013	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	26003000
CY2013	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	695000
CY2013	us-gaap	Sales Revenue Net SalesRevenueNet	264058000
CY2013	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	4637000
CY2013	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	8273000
CY2013	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4833000
CY2013	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	52213000
CY2013	us-gaap	Costs And Expenses CostsAndExpenses	199357000
CY2013	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	47000
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8881000
CY2013	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	695000
CY2013	us-gaap	Dividends Common Stock DividendsCommonStock	4838000
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2369000
CY2013	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	459000
CY2013	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	9164000
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	402000
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	2743000
CY2013	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4384000
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1227000
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1422000
CY2013	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	22000000
CY2013	us-gaap	Interest Expense InterestExpense	538000
CY2013	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1814000
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	10415000
CY2013	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	806000
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1970000
CY2013	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	3180000
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-52449000
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	105000
CY2013	us-gaap	Proceeds From Sale Of Interest In Partnership Unit ProceedsFromSaleOfInterestInPartnershipUnit	200000
CY2013	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-48000
CY2013	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	859000
CY2013	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	150800000
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	399000
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5562000
CY2013	us-gaap	Interest Expense On Prepetition Liabilities Recognized In Statement Of Operations InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations	0
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	893000
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	9867000
CY2013	us-gaap	Restructuring Charges RestructuringCharges	246000
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0
CY2013	us-gaap	Labor And Related Expense LaborAndRelatedExpense	141840000
CY2013	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2013	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0
CY2013	us-gaap	Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent	1900000
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	8445000
CY2013	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12236000
CY2013	usph	Share Based Compensation Arrangement By Share Based Payment Share Granted To Employees Lapse In Equal Installments Description ShareBasedCompensationArrangementByShareBasedPaymentShareGrantedToEmployeesLapseInEqualInstallmentsDescription	Shares granted to employees lapse in equal installments on the following four or five annual anniversaries of the date of grant
CY2013	usph	Compensation Expense Restricted Stock CompensationExpenseRestrictedStock	2743000
CY2013	usph	Effective Date Of Reduction In Medicare Physician Fee Payment Rate EffectiveDateOfReductionInMedicarePhysicianFeePaymentRate	2013-04-01
CY2013	usph	Acquisitions Of Noncontrolling Interests AcquisitionsOfNoncontrollingInterests	1876000
CY2013	usph	Amount Of Reductions In Federal Spending AmountOfReductionsInFederalSpending	1200000000000
CY2013	usph	Number Of Separate Transactions To Purchase Partnership Interest NumberOfSeparateTransactionsToPurchasePartnershipInterest	15	Transactions
CY2013	usph	Reduction In Medicare Spending Percentage ReductionInMedicareSpendingPercentage	0.02	pure
CY2013	usph	Share Based Compensation Expense ShareBasedCompensationExpense	4200000
CY2013	usph	Number Of Clinic Acquired NumberOfClinicAcquired	3	Clinic
CY2013	usph	Percentage Increase In Payment Reduction In Institutional Or Non Institutional Setting PercentageIncreaseInPaymentReductionInInstitutionalOrNonInstitutionalSetting	0.50	pure
CY2013	usph	Percentage Of Limited Partnership Interest Owned PercentageOfLimitedPartnershipInterestOwned	0.64	pure
CY2013	usph	Difference Between Net Revenues And Corresponding Cash Collections Reflected Percentage Of Net Revenues DifferenceBetweenNetRevenuesAndCorrespondingCashCollectionsReflectedPercentageOfNetRevenues	0.01	pure
CY2013	usph	Business Acquisition Cost Of Acquired Entity Charge From Undistributed Earning BusinessAcquisitionCostOfAcquiredEntityChargeFromUndistributedEarning	100000
CY2013	usph	Maximum Difference Between Actual Aggregate Contractual Reserve Percentages As Compared To Estimated Contractual Allowance Reserve Percentage MaximumDifferenceBetweenActualAggregateContractualReservePercentagesAsComparedToEstimatedContractualAllowanceReservePercentage	0.01	pure
CY2013	usph	Percentage Reduction For Service In Office Or Other Non Institutional Settings PercentageReductionForServiceInOfficeOrOtherNonInstitutionalSettings	0.20	pure
CY2013	usph	Percentage Of General Partnership Interest Owned PercentageOfGeneralPartnershipInterestOwned	0.01	pure
CY2013	usph	Share Based Compensation Arrangement By Share Based Payment Award Expiration Period Description ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriodDescription	2014 through 2017
CY2013	usph	Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans	248000
CY2013	usph	Interest And Other Income Net InterestAndOtherIncomeNet	7000
CY2013	usph	Increase Decrease In Patient Accounts Receivable IncreaseDecreaseInPatientAccountsReceivable	5389000
CY2013	usph	Purchase Of Business Seller Financing Portion PurchaseOfBusinessSellerFinancingPortion	1300000
CY2013	usph	Number Of Partnership In Which Interest Acquired NumberOfPartnershipInWhichInterestAcquired	10	Partnership
CY2013	usph	Employment Agreements Expiration Date EmploymentAgreementsExpirationDate	2015-12-31
CY2013	usph	Rent Clinic Supplies Contract Labor And Other RentClinicSuppliesContractLaborAndOther	52887000
CY2013	usph	Percentage Reduction For Service In Institutional Settings PercentageReductionForServiceInInstitutionalSettings	0.25	pure
CY2013	usph	Period Of Federal Debt Ceiling In Connection With Deficit Reductions PeriodOfFederalDebtCeilingInConnectionWithDeficitReductions	P10Y
CY2013	usph	Corporate Office Costs CorporateOfficeCosts	25931000
CY2013	usph	Percentage Of Practice Expense Component Of Relative Value Unit PercentageOfPracticeExpenseComponentOfRelativeValueUnit	1.00	pure
CY2013	usph	Percentage Of Reduction Prevented PercentageOfReductionPrevented	0.201	pure
CY2013	usph	Minimum Percentage Of Fair Value Reporting Unit Less Than Carrying Amount MinimumPercentageOfFairValueReportingUnitLessThanCarryingAmount	0.50	pure
CY2013	usph	Defined Contribution Plan Period For New Employees Covered Under Plan DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan	P3M
CY2013	usph	Minimum Difference Between Actual Aggregate Contractual Reserve Percentages Compared To Estimated Contractual Allowance Reserve Percentage MinimumDifferenceBetweenActualAggregateContractualReservePercentagesComparedToEstimatedContractualAllowanceReservePercentage	0.01	pure
CY2013	usph	Proceeds From Sale Of Non Controlling Interest Fixed Assets And Business ProceedsFromSaleOfNonControllingInterestFixedAssetsAndBusiness	233000
CY2013	usph	Number Of Third Party Facilities NumberOfThirdPartyFacilities	18	Facility
CY2013	usph	Number Of Clinic Operated Under Separate Partnership NumberOfClinicOperatedUnderSeparatePartnership	2	Clinic
CY2013	usph	Number Of Clinic Operated Under Existing Partnership NumberOfClinicOperatedUnderExistingPartnership	5	Clinic
CY2013	usph	Business Acquisition Cost Of Acquired Entity Charge From Additional Paid Up Capital BusinessAcquisitionCostOfAcquiredEntityChargeFromAdditionalPaidUpCapital	1000000
CY2013	usph	Effective Income Tax Rate Reconciliation Deductible Losses EffectiveIncomeTaxRateReconciliationDeductibleLosses	0.003	pure
CY2013	usph	Income Tax Reconciliation Deductible Losses IncomeTaxReconciliationDeductibleLosses	-98000
CY2013	usph	Income Tax Reconciliation Income Tax Expense Benefit Non Taxable Gain IncomeTaxReconciliationIncomeTaxExpenseBenefitNonTaxableGain
CY2012	us-gaap	Increase Decrease In Accounts Receivable And Other Operating Assets IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets	561000
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	220	shares
CY2012	us-gaap	Weighted Average Basic Shares Outstanding Pro Forma WeightedAverageBasicSharesOutstandingProForma	11804	shares
CY2012	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11904000	shares
CY2013	usph	Share Based Compensation Arrangement By Share Based Payment Award For Shares Outstanding Restrictions Had Not Lapsed ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed	244018	shares
CY2013	usph	Renewal Period For Employment RenewalPeriodForEmployment	P1Y
CY2013	usph	Reclass To Redeemable Non Controlling Interests ReclassToRedeemableNonControllingInterests	-4104000
CY2013	usph	Increase In Current State Income Tax IncreaseInCurrentStateIncomeTax	393000
CY2013	usph	Change Of Medicare Reimbursement Annual Limit Effective Date ChangeOfMedicareReimbursementAnnualLimitEffectiveDate	2014-01-01
CY2013	usph	Proceeds From Sale Of Interest In Partnership Unit In Cash ProceedsFromSaleOfInterestInPartnershipUnitInCash	600000
CY2013	usph	Proceeds From Sale Of Interest In Partnership Unit In Notes Receivable ProceedsFromSaleOfInterestInPartnershipUnitInNotesReceivable	800000
CY2013	usph	Gain Loss On Sale Or Abandonment Of Assets Net GainLossOnSaleOrAbandonmentOfAssetsNet	-7335000
CY2012	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.02
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	80650	shares
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	17.89
CY2012	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.51
CY2012	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.76
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350	pure
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2012	us-gaap	Pro Forma Weighted Average Shares Outstanding Diluted ProFormaWeightedAverageSharesOutstandingDiluted	11904	shares
CY2012	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.52
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y2M12D
CY2012	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	1.69
CY2012	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.381	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.003	pure
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2012	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	100000	shares
CY2012	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	1.67
CY2012	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.02
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	39249000
CY2012	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.54
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	14.12
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	21.65
CY2012	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11804000	shares
CY2012	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	12.51
CY2012	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	272750	shares
CY2012	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.042	pure
CY2012	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.53
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2012	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2012	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	18.80
CY2012	us-gaap	Interest Paid Net InterestPaidNet	639000
CY2012	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	2892000
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	2102000
CY2012	us-gaap	Gross Profit GrossProfit	62910000
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	37855000
CY2012	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	6361000
CY2012	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	9017000
CY2012	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	434000
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-423000
CY2012	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	7929000
CY2012	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	86000000
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-279000
CY2012	us-gaap	Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax	19894000
CY2012	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	22000
CY2012	us-gaap	Profit Loss ProfitLoss	26217000
CY2012	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	585000
CY2012	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	1351000
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	38406000
CY2012	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	5551000
CY2012	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	261231000
CY2012	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	18212000
CY2012	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	9332000
CY2012	us-gaap	Net Income Loss NetIncomeLoss	17933000
CY2012	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	244100000
CY2012	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	26640000
CY2012	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	1209000
CY2012	us-gaap	Sales Revenue Net SalesRevenueNet	249651000
CY2012	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	4234000
CY2012	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	8284000
CY2012	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-340000
CY2012	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	10538000
CY2012	us-gaap	Costs And Expenses CostsAndExpenses	186741000
CY2012	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	75000
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-23457000
CY2012	us-gaap	Deferred Tax Expense From Stock Options Exercised DeferredTaxExpenseFromStockOptionsExercised	1351000
CY2012	us-gaap	Dividends Common Stock DividendsCommonStock	9017000
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3738000
CY2012	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	64000
CY2012	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	9332000
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3459000
CY2012	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4824000
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1688000
CY2012	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	360000
CY2012	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	20800000
CY2012	us-gaap	Interest Expense InterestExpense	557000
CY2012	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1219000
CY2012	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	10299000
CY2012	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	1199000
CY2012	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	3183000
CY2012	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	181000
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14104000
CY2012	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	101000
CY2012	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	200000
CY2012	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1381000
CY2012	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	79900000
CY2012	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	555000
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5287000
CY2012	us-gaap	Interest Expense On Prepetition Liabilities Recognized In Statement Of Operations InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations	0
CY2012	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	239000
CY2012	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	838000
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	7477000
CY2012	us-gaap	Restructuring Charges RestructuringCharges	211000
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0
CY2012	us-gaap	Labor And Related Expense LaborAndRelatedExpense	131604000
CY2012	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2012	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0
CY2012	us-gaap	Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent	2200000
CY2012	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	7117000
CY2012	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11215000
CY2012	usph	Compensation Expense Restricted Stock CompensationExpenseRestrictedStock	2102000
CY2012	usph	Acquisitions Of Noncontrolling Interests AcquisitionsOfNoncontrollingInterests	2244000
CY2012	usph	Number Of Separate Transactions To Purchase Partnership Interest NumberOfSeparateTransactionsToPurchasePartnershipInterest	15	Transactions
CY2012	usph	Number Of Clinic Acquired NumberOfClinicAcquired	7	Clinic
CY2012	usph	Business Acquisition Cost Of Acquired Entity Charge From Undistributed Earning BusinessAcquisitionCostOfAcquiredEntityChargeFromUndistributedEarning	200000
CY2012	usph	Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans	135000
CY2012	usph	Purchase Of Business Seller Financing Portion PurchaseOfBusinessSellerFinancingPortion	350000
CY2012	usph	Number Of Partnership In Which Interest Acquired NumberOfPartnershipInWhichInterestAcquired	15	Partnership
CY2012	usph	Interest And Other Income Net InterestAndOtherIncomeNet	6000
CY2012	usph	Increase Decrease In Patient Accounts Receivable IncreaseDecreaseInPatientAccountsReceivable	1663000
CY2012	usph	Rent Clinic Supplies Contract Labor And Other RentClinicSuppliesContractLaborAndOther	50102000
CY2012	usph	Corporate Office Costs CorporateOfficeCosts	24504000
CY2012	usph	Proceeds From Sale Of Non Controlling Interest Fixed Assets And Business ProceedsFromSaleOfNonControllingInterestFixedAssetsAndBusiness	239000
CY2012	usph	Number Of Clinic Operated Under Separate Partnership NumberOfClinicOperatedUnderSeparatePartnership	2	Clinic
CY2012	usph	Number Of Clinic Operated Under Existing Partnership NumberOfClinicOperatedUnderExistingPartnership	5	Clinic
CY2012	usph	Number Of Partnership In Interest Sale By Parent NumberOfPartnershipInInterestSaleByParent	3	PartnershipUnit
CY2012	usph	Business Acquisition Cost Of Acquired Entity Charge From Additional Paid Up Capital BusinessAcquisitionCostOfAcquiredEntityChargeFromAdditionalPaidUpCapital	2000000
CY2012	usph	Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Sale Of Interest Amount Credit To Additional Paid Up Capital ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestAmountCreditToAdditionalPaidUpCapital	5000
CY2012	usph	Effective Income Tax Rate Reconciliation Deductible Losses EffectiveIncomeTaxRateReconciliationDeductibleLosses	0.014	pure
CY2012	usph	Income Tax Reconciliation Deductible Losses IncomeTaxReconciliationDeductibleLosses	-404000
CY2012	usph	Income Tax Reconciliation Income Tax Expense Benefit Non Taxable Gain IncomeTaxReconciliationIncomeTaxExpenseBenefitNonTaxableGain
CY2012	usph	Adjustment To State And Local Tax Expense Benefit AdjustmentToStateAndLocalTaxExpenseBenefit	162000
CY2012	usph	Contribution Of Noncontrolling Interests Partners ContributionOfNoncontrollingInterestsPartners	49000
CY2012	usph	Exercisable Noncontrolling Interest With Put Rights ExercisableNoncontrollingInterestWithPutRights	0
CY2012	usph	Gain Loss On Sale Or Abandonment Of Assets Net GainLossOnSaleOrAbandonmentOfAssetsNet	-175000
CY2013Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.01
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.31
CY2013Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11979000	shares
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.31
CY2013Q1	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.01
CY2013Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.32
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11955000	shares
CY2013Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.32
CY2013Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-130000
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	8435000
CY2013Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	3851000
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	3721000
CY2013Q1	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	61432000
CY2013Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	5809000
CY2013Q1	us-gaap	Sales Revenue Net SalesRevenueNet	62756000
CY2012Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.37
CY2012Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11979000	shares
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.37
CY2012Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.37
CY2012Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11955000	shares
CY2012Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.37
CY2012Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	42000
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	9765000
CY2012Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	4436000
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	4478000
CY2012Q1	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	60366000
CY2012Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	6733000
CY2012Q1	us-gaap	Sales Revenue Net SalesRevenueNet	61771000
CY2012Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.01
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.40
CY2012Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12110000	shares
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.40
CY2012Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.01
CY2012Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.41
CY2012Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12089000	shares
CY2012Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.41
CY2012Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-109000
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	10806000
CY2012Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	4958000
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	4849000
CY2012Q2	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	61963000
CY2012Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	7452000
CY2012Q2	us-gaap	Sales Revenue Net SalesRevenueNet	63397000
CY2013Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.01
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.41
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12110000	shares
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.41
CY2013Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.01
CY2013Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.42
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12089000	shares
CY2013Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.42
CY2013Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-165000
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	11059000
CY2013Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	5079000
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	4914000
CY2013Q2	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	65227000
CY2013Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	7642000
CY2013Q2	us-gaap	Sales Revenue Net SalesRevenueNet	66868000
CY2012Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.38
CY2012Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12120000	shares
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.39
CY2012Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.39
CY2012Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12106000	shares
CY2012Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.38
CY2012Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-25000
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	9534000
CY2012Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	4588000
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	4563000
CY2012Q3	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	60719000
CY2012Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	6423000
CY2012Q3	us-gaap	Sales Revenue Net SalesRevenueNet	62102000
CY2013Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.36
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2013Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12120000	shares
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2013Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.36
CY2013Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.38
CY2013Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12106000	shares
CY2013Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.38
CY2013Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-4432000
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	9904000
CY2013Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	4659000
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	227000
CY2013Q3	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	64368000
CY2013Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	6756000
CY2013Q3	us-gaap	Sales Revenue Net SalesRevenueNet	65829000
CY2012Q4	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.02
CY2012Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.33
CY2012Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12117000	shares
CY2012Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.33
CY2012Q4	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.02
CY2012Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.35
CY2012Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12103000	shares
CY2012Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.35
CY2012Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-187000
CY2012Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	8301000
CY2012Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	4230000
CY2012Q4	us-gaap	Net Income Loss NetIncomeLoss	4043000
CY2012Q4	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	61052000
CY2012Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	6032000
CY2012Q4	us-gaap	Sales Revenue Net SalesRevenueNet	62381000
CY2013Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2013Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12117000	shares
CY2013Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.32
CY2013Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.32
CY2013Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12103000	shares
CY2013Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.32
CY2013Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-42000
CY2013Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	9372000
CY2013Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	3903000
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	3861000
CY2013Q4	us-gaap	Health Care Organization Patient Service Revenue HealthCareOrganizationPatientServiceRevenue	67256000
CY2013Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	5796000
CY2013Q4	us-gaap	Sales Revenue Net SalesRevenueNet	68605000

Files In Submission

Name	View Source	Status
0001193125-14-093159-index-headers.html	Edgar Link	pending
0001193125-14-093159-index.html	Edgar Link	pending
0001193125-14-093159.txt	Edgar Link	pending
0001193125-14-093159-xbrl.zip	Edgar Link	pending
d660142d10k.htm	Edgar Link	pending
d660142dex211.htm	Edgar Link	pending
d660142dex231.htm	Edgar Link	pending
d660142dex311.htm	Edgar Link	pending
d660142dex312.htm	Edgar Link	pending
d660142dex313.htm	Edgar Link	pending
d660142dex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
g660142g35l38.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
usph-20131231.xml	Edgar Link	completed
usph-20131231.xsd	Edgar Link	pending
usph-20131231_cal.xml	Edgar Link	unprocessable
usph-20131231_def.xml	Edgar Link	unprocessable
usph-20131231_lab.xml	Edgar Link	unprocessable
usph-20131231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$USPH
U S PHYSICAL THERAPY INC /NV Stock $usph

2013 Q4 Form 10-K Financial Statement

#000119312514093159 Filed on March 11, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$USPH U S PHYSICAL THERAPY INC /NV Stock $usph

2013 Q4 Form 10-K Financial Statement

#000119312514093159 Filed on March 11, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$USPH
U S PHYSICAL THERAPY INC /NV Stock $usph